Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
暂无分享,去创建一个
E. R. van den Heuvel | E. Hak | S. la Bastide-van Gemert | H. Englund | J. Castilla | J. McAnerney | Motoi Suzuki | Wanting Huang | N. Turner | G. Gefenaite | C. Cohen | I. Martínez-Baz | A. Bissielo | G. Ntshoe | M. Darvishian
[1] E. R. van den Heuvel,et al. Confidence intervals for intraclass correlation coefficients in variance components models , 2016, Statistical methods in medical research.
[2] Nicholas S. Kelley,et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. , 2016, The Lancet. Infectious diseases.
[3] D. Skowronski,et al. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] D. Skowronski,et al. Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] L. Blumberg,et al. Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014 , 2015, Influenza and other respiratory viruses.
[6] F. Pozo,et al. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus , 2015, Human vaccines & immunotherapeutics.
[7] L. Blumberg,et al. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010–2013 , 2015, Influenza and other respiratory viruses.
[8] O. Wichmann,et al. Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis , 2015, BMC Medicine.
[9] D. Skowronski,et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.
[10] E. R. van den Heuvel,et al. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. , 2014, The Lancet. Infectious diseases.
[11] H. Kelly,et al. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] T. Friedrich,et al. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] H. Kelly,et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[14] M. Haber,et al. A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies , 2014, Epidemiology and Infection.
[15] C Moore,et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[16] H. Kelly,et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. , 2014, Vaccine.
[17] L. Blumberg,et al. Influenza Epidemiology and Vaccine Effectiveness among Patients with Influenza-Like Illness, Viral Watch Sentinel Sites, South Africa, 2005–2009 , 2014, PloS one.
[18] U. Buchholz,et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[19] K. Ariyoshi,et al. Vaccine Effectiveness against Medically Attended Laboratory-Confirmed Influenza in Japan, 2011–2012 Season , 2014, PloS one.
[20] E. Hak,et al. Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania. , 2014, Vaccine.
[21] H. Kelly,et al. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[22] D. Skowronski,et al. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[23] H. Kelly,et al. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] J. Castilla,et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study , 2013, BMC Public Health.
[25] Wen-Ta Chiu,et al. Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season , 2013, PloS one.
[26] F. Pozo,et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[27] M. Valenciano,et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[28] K. Ariyoshi,et al. Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan , 2013, PloS one.
[29] W. Hautmann,et al. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season , 2012, Epidemiology and Infection.
[30] H. Kelly,et al. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011 , 2012, Influenza and other respiratory viruses.
[31] J. Castilla,et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. , 2012, Vaccine.
[32] Catrin Tudur Smith,et al. Individual participant data meta-analyses compared with meta-analyses based on aggregate data , 2011, The Cochrane database of systematic reviews.
[33] M. Valenciano,et al. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe , 2011, PloS one.
[34] C. Siegrist,et al. Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience , 2011, Ageing Research Reviews.
[35] Peter G Szilagyi,et al. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. , 2010, The Journal of infectious diseases.
[36] Edwin R. van den Heuvel,et al. A Comparison of Estimation Methods on the Coverage Probability of Satterthwaite Confidence Intervals for Assay Precision with Unbalanced Data , 2010, Commun. Stat. Simul. Comput..
[37] Keiji Fukuda,et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. , 2010, Vaccine.
[38] L. Hedges,et al. The Handbook of Research Synthesis and Meta-Analysis , 2009 .
[39] Kristina Grant,et al. Estimation of Influenza Vaccine Effectiveness from Routine Surveillance Data , 2009, PloS one.
[40] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[41] A. Hoes,et al. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications , 2002, Journal of epidemiology and community health.
[42] K. Nichol,et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[44] Theo Stijnen,et al. Advanced methods in meta‐analysis: multivariate approach and meta‐regression , 2002, Statistics in medicine.
[45] H C Van Houwelingen,et al. A bivariate approach to meta-analysis. , 1993, Statistics in medicine.